These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1428567)

  • 1. Effects of timolol on visual-field mean retinal sensitivity in normal subjects.
    Martin XD; Fankhauser F; Rabineau PA
    Int Ophthalmol; 1992 Sep; 16(4-5):325-9. PubMed ID: 1428567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latanoprost-induced stabilization of central visual function in patients with primary open-angle glaucoma.
    Evans DW; Bartlett JD; Houde B; Than TP; Shaikh A
    J Ocul Pharmacol Ther; 2008 Apr; 24(2):224-9. PubMed ID: 18355134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoconstrictive effect of topical timolol on human retinal arteries.
    Martin XD; Rabineau PA
    Graefes Arch Clin Exp Ophthalmol; 1989; 227(6):526-30. PubMed ID: 2625208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timolol treatment prevents or delays glaucomatous visual field loss in individuals with ocular hypertension: a five-year, randomized, double-masked, clinical trial.
    Kass MA
    Trans Am Ophthalmol Soc; 1989; 87():598-618. PubMed ID: 2562546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.
    Krupin T; Liebmann JM; Greenfield DS; Rosenberg LF; Ritch R; Yang JW;
    Ophthalmology; 2005 Mar; 112(3):376-85. PubMed ID: 15745762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longterm effect of topical beta-blockers on intraocular pressure and visual field sensitivity in ocular hypertension and chronic open-angle glaucoma.
    Collignon-Brach J
    Surv Ophthalmol; 1994 May; 38 Suppl():S149-55. PubMed ID: 7940136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longterm visual field follow-up of glaucoma patients treated with beta-blockers.
    Kaiser HJ; Flammer J; Stümpfig D; Hendrickson P
    Surv Ophthalmol; 1994 May; 38 Suppl():S156-9; discussion S160. PubMed ID: 7940137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of betaxolol and timolol on the visual fields of patients with glaucoma.
    Messmer C; Flammer J; Stümpfig D
    Am J Ophthalmol; 1991 Dec; 112(6):678-81. PubMed ID: 1957903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of betaxolol and timolol on visual fields in glaucoma patients].
    Messmer C; Stümpfig D; Flammer J
    Klin Monbl Augenheilkd; 1991 May; 198(5):330-1. PubMed ID: 1886348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The favorable effect of topical betaxolol and timolol on glaucomatous visual fields: a 2-year follow-up study.
    Vainio-Jylhä E; Vuori ML
    Graefes Arch Clin Exp Ophthalmol; 1999 Feb; 237(2):100-4. PubMed ID: 9987624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraocular pressure effects of timolol after unilateral instillation.
    Martin XD; Rabineau PA
    Ophthalmology; 1988 Dec; 95(12):1620-3. PubMed ID: 2906744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of timolol versus pilocarpine on visual field progression in patients with primary open-angle glaucoma.
    Vogel R; Crick RP; Mills KB; Reynolds PM; Sass W; Clineschmidt CM; Tipping R
    Ophthalmology; 1992 Oct; 99(10):1505-11. PubMed ID: 1454315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification and monitoring of visual field defects and a prospective, randomized comparison of pilocarpine and timolol using computerized perimetry.
    Sponsel WE
    Surv Ophthalmol; 1989 Apr; 33 Suppl():427-8; discussion 435-6. PubMed ID: 2749512
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects on the intraocular pressure and visual field resulting from a switch in the treatment from timolol to betaxolol.
    Miki H; Miki K
    J Ocul Pharmacol Ther; 2004 Dec; 20(6):509-17. PubMed ID: 15684810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short term effects of timolol in chronic glaucoma. A double blind study using computerized perimetry.
    Holmin C; Krakau CE
    Acta Ophthalmol (Copenh); 1982 Jun; 60(3):337-46. PubMed ID: 7136544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study.
    Krupin T; Liebmann JM; Greenfield DS; Ritch R; Gardiner S;
    Am J Ophthalmol; 2011 Apr; 151(4):671-81. PubMed ID: 21257146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for visual field progression in the low-pressure glaucoma treatment study.
    De Moraes CG; Liebmann JM; Greenfield DS; Gardiner SK; Ritch R; Krupin T;
    Am J Ophthalmol; 2012 Oct; 154(4):702-11. PubMed ID: 22835512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of timolol maleate on untreated contralateral eyes (author's transl)].
    Spinelli D; Montanari P; Vigasio F; Cormanni V
    J Fr Ophtalmol; 1982; 5(3):153-8. PubMed ID: 7096893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of two weeks of timolol maleate treatment on the normal retinal circulation.
    Grunwald JE
    Invest Ophthalmol Vis Sci; 1991 Jan; 32(1):39-45. PubMed ID: 1987105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.